You have 9 free searches left this month | for more free features.

Vilazodone Hydrochloride

Showing 26 - 50 of 1,793

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston

Active, not recruiting
  • Metastatic Urothelial Carcinoma
  • +2 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Oxycodone Sustained-release Tablets for Moderate to Severe

Recruiting
  • Cancer Pain
  • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 24, 2023

    Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Anamorelin Hydrochloride, Placebo,

    Active, not recruiting
    • Anorexia
    • +8 more
    • Anamorelin Hydrochloride
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Third Molar Extraction Trial in São Paulo (FDC of etoricoxib + cyclobenzaprine + etoricoxib , etoricoxib 90 mg (Arcoxia®) +FDC ,

    Not yet recruiting
    • Third Molar Extraction
    • FDC of etoricoxib + cyclobenzaprine + etoricoxib placebo
    • +2 more
    • São Paulo, SP, Brazil
      Eurofarma Laboratorios S.A
    Jan 11, 2023

    Solid Tumor Trial in Jacksonville, Rochester (Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Pharmacological Study)

    Active, not recruiting
    • Solid Neoplasm
    • Laboratory Biomarker Analysis
    • +2 more
    • Jacksonville, Florida
    • +1 more
    Jan 25, 2023

    Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United

    Recruiting
    • Advanced Lung Non-Small Cell Carcinoma
    • +2 more
    • Birmingham, Alabama
    • +10 more
    Jan 25, 2023

    Parkinson Disease Trial (Ambroxol Hydrochloride (420mg), Placebo)

    Not yet recruiting
    • Parkinson Disease
    • Ambroxol Hydrochloride (420mg)
    • Placebo
    • (no location specified)
    Mar 9, 2023

    Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)

    Not yet recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • Mitoxantrone Hydrochloride Liposome Injection
    • (no location specified)
    Sep 20, 2022

    Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

    Active, not recruiting
    • Ann Arbor Stage III Non-Hodgkin Lymphoma
    • +2 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 28, 2023

    Breast Reduction Trial in Rochester (Bupivacaine Hydrochloride, Liposomal Bupivacaine)

    Not yet recruiting
    • Breast Reduction
    • Bupivacaine Hydrochloride
    • Liposomal Bupivacaine
    • Rochester, Minnesota
      Mayo Clinic Minnesota
    May 26, 2023

    Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)

    Recruiting
    • Soft Tissue Sarcoma
    • Fluzoparib
    • Preoperative moderately fractionated radiotherapay
    • Beijing, Beijing, China
    • +1 more
    Jul 3, 2023

    Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)

    Active, not recruiting
    • Prostate Cancer
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 4, 2022

    Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

    Active, not recruiting
    • Advanced Soft Tissue Sarcoma
    • +26 more
    • Doxorubicin Hydrochloride
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 6, 2023

    Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,

    Completed
    • Adult Angiosarcoma
    • +3 more
    • pazopanib hydrochloride
    • +4 more
    • Chicago, Illinois
    • +4 more
    Jul 26, 2022

    Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

    Recruiting
    • Mantle Cell Lymphoma
    • New Orleans, Louisiana
    • +5 more
    Dec 13, 2022

    Richter Syndrome Trial in United States (Venetoclax, DA-EPOCH-R, R-CHOP)

    Recruiting
    • Richter Syndrome
    • Boston, Massachusetts
    • +2 more
    Jan 6, 2023

    ADHD, ADHD Trial in Irvine (Methylphenidate Hydrochloride Extended Release Capsules, Placebo)

    Completed
    • Attention Deficit Hyperactivity Disorder
    • ADHD
    • Methylphenidate Hydrochloride Extended Release Capsule
    • Placebo
    • Irvine, California
      University of California, Irvine/Child Development Center
    Nov 16, 2022

    Pain Trial (Advil PM Liqui-Gels Minis, Advil PM Liqui-Gels)

    Not yet recruiting
    • Pain
    • Advil PM Liqui-Gels Minis
    • Advil PM Liqui-Gels
    • (no location specified)
    Jan 5, 2023

    Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

    Recruiting
    • Fallopian Tube Carcinosarcoma
    • +28 more
    • Pegylated Liposomal Doxorubicin Hydrochloride
    • Peposertib
    • Aurora, Colorado
    • +7 more
    Sep 2, 2022

    Advanced Cancers Trial in Houston (Temsirolimus, Metformin)

    Active, not recruiting
    • Advanced Cancers
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 11, 2022

    MDD Trial in Canada, United States (Vilazodone)

    Completed
    • Major Depressive Disorder
    • Birmingham, Alabama
    • +55 more
    Sep 10, 2019

    DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • Mitoxantrone Hydrochloride Liposome Injection
    • Jinan, Shandong, China
      Affiliated Cancer Hospital of Shandong First Medical University
    May 16, 2023

    Interstitial Lung Diseases Trial in Wenzhou (Anlotinib, Placebo)

    Recruiting
    • Interstitial Lung Diseases
    • Wenzhou, Zhejiang, China
      The First Affiliated Hospital of Wenzhou Medical University
    Apr 13, 2023

    Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)

    Completed
    • Metastatic Cancer
    • Unspecified Adult Solid Tumor
    • PARP inhibitor BMN-673
    • +4 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Sep 22, 2022

    Relapsed/Refractory Multiple Myeloma Trial in Suzhou (Mitoxantrone HCl liposome/Dexamethasone/daratumumab)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab
    • Suzhou, Jiangsu, China
      Second Affiliated Hospital of Soochow University
    May 4, 2023